Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Interdisciplinary Hemophilia A Education: Conversation Between a Hematologist and a Social Worker
  • CME
  • CE

Credits Available
Physicians: maximum of 0.25 AMA PRA Category 1 Credits
Registered Nurses: 0.25 Nursing contact hours
Pharmacists: 0.25 contact hours (0.025 CEUs)
Released: April 8, 2022 Expiration: April 7, 2023
Start Activity
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

In partnership with the
Supported by an educational grant from
Genentech, a member of the Roche Group
Glaivy Batsuli, MD
person default
Jamilah Hill, MSW, LCSW

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Implement strategies to optimize adherence to prophylaxis therapy in patients with hemophilia A, especially among the adolescent/young adult population
  • Equip adolescents/young adults and other appropriate patients with hemophilia A, through counseling and education, to assume autonomous care for much of their hemophilia prophylaxis

Information on this Educational Activity

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Faculty

Glaivy Batsuli, MD

Assistant Professor of Pediatrics
Pediatric Hematologist
Division of Pediatric Hematology and Oncology
Department of Pediatrics
Emory University and Children's Healthcare of Atlanta
Atlanta, Georgia

Glaivy Batsuli, MD, has disclosed that she has received consultant/advisor/speaker fees from Bio Products Laboratories and Kedrion.
Jamilah Hill, MSW, LCSW

Congenital Bleeding Disorders Social Worker
Comprehensive Bleeding Disorders Center
Emory University & Children’s Healthcare of Atlanta, Inc.
Atlanta, Georgia

Jamilah Hill, MSW, LCSW, has no relevant conflicts of interest to disclose.

Staff

Shara Pantry, PhD

Associate Scientific Director

Shara Pantry, PhD, has no relevant conflicts of interest to report.
Megan Cartwright, PhD

Senior Clinical Editor

Megan Cartwright, PhD, has no relevant conflicts of interest to report.
Kristen Morrow, PhD

Editorial Contributor

Kristen Morrow, PhD, has no relevant conflicts of interest to report.
Kristen Rosenthal, PhD

Associate Director, Scientific Services

Kristen M. Rosenthal, PhD, has no relevant conflicts of interest to report.
Timothy A. Quill, PhD

Associate Director, Scientific Services

Timothy A. Quill, PhD, has no relevant conflicts of interest to report.
June Wasserstrom

Director, CME Program Development

June Wasserstrom has no relevant conflicts of interest to report.
Kevin Obholz, PhD

Senior Director, Educational Strategy

Kevin Obholz, PhD, has no relevant conflicts of interest to report.
Kristi Kay Orbaugh, MSN, NP, AOCNP

Adult Oncology Nurse Practitioner
Community Hospital Oncology Physicians
Indianapolis, Indiana

Kristi Orbaugh, MSN, NP, AOCNP has disclosed that she has served as a speaker for AstraZeneca, Bristol-Myers Squibb, DSI, Gilead Sciences, Lilly, Morphosys, Pfizer, Regeneron, and Sanofi.
Kelly Brandt, PharmD
Kelly Brandt, PharmD, has no relevant conflicts of interest to report.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This educational program is intended for all healthcare professionals across multiple disciplines and specialties who care for patients with hemophilia A, including hematologists, nurse practitioners, pharmacists/managed care professionals, surgeons, pathologists, and social workers/mental health professionals.

Goal

The goal of this program is to improve the knowledge, competence, and performance of healthcare professionals involved in the management of patients with hemophilia A, in the benefits of prophylaxis therapy and adherence to treatment regimens for patients with hemophilia A.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Credit Designation

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.25 contact hours.

Continuing Pharmacy Education

Credit Designation

CCO designates this continuing education activity for 0.25 contact hours (0.025 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-22-105-H01-P.

Type of Activity: Knowledge

Upon successfully completing the post-test with a score of 100% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from April 08, 2022, through April 07, 2023:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 100% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Interdisciplinary Hemophilia A Education: Conversation Between a Hematologist and a Social Worker
  • CME
  • CE

Loading...
Hear about the important roles social workers play in addressing psychosocial support, financial needs, and barriers to care for patients with hemophilia A in this interactive presentation.
Glaivy Batsuli, MD
person default
Jamilah Hill, MSW, LCSW
Physicians: maximum of 0.25 AMA PRA Category 1 Credits
Registered Nurses: 0.25 Nursing contact hours
Pharmacists: 0.25 contact hours (0.025 CEUs)
Released: April 8, 2022 Expiration: April 7, 2023

Related Content

Expert text module from Dr. Catherine Shu on clinical trial highlights for EGFR-mutated advanced NSCLC, from Clinical Care Options (CCO)

person default Catherine A. Shu, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: September 30, 2022 Expired: September 29, 2023

Expert slides from Dr. Catherine Shu on clinical trial highlights for EGFR-mutated advanced NSCLC, from Clinical Care Options (CCO)

person default Catherine A. Shu, MD Released: September 30, 2022

Experts review oncology HCP survey results on key educational needs in managing EGFR-mutated NSCLC, including discussion of SoC practices and ongoing challenges, from Clinical Care Options (CCO)

Edward B. Garon, MD, MS
Program Director
Xiuning Le, MD, PhD Zofia Piotrowska, MD, MHS Mark A. Socinski, MD Helena A. Yu, MD
Physicians: maximum of 1.25 AMA PRA Category 1 Credits Registered Nurses: 1.25 Nursing contact hours Pharmacists: 1.25 contact hours (0.125 CEUs) Released: September 30, 2022 Expired: September 29, 2023

Slides from expert panel on standard-of-care practices and ongoing challenges in managing EGFR-mutated NSCLC, from Clinical Care Options (CCO)

Edward B. Garon, MD, MS
Program Director
Xiuning Le, MD, PhD Zofia Piotrowska, MD, MHS Mark A. Socinski, MD Helena A. Yu, MD
Released: September 30, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings